Mogling Bio is developing pharmacological methods to inhibit elevated Cdc42 activity in aging hematopoietic stem cells, which leads to disordered blood cell production and contributes to diseases like leukemia. By rejuvenating these stem cells, the company aims to restore immune function and improve treatment outcomes for blood-related disorders.
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Aging hematopoietic stem cells (HSCs) exhibit elevated Cdc42 activity, leading to disordered blood cell production. This impairment contributes to the decline in immune function and the development of blood-related disorders, such as leukemia and myelodysplasia syndromes.
Solution
Mogling Bio is developing pharmacological interventions to inhibit elevated Cdc42 activity in aged HSCs, thereby rejuvenating these cells and restoring proper blood cell production. By targeting Cdc42, the company aims to re-establish the normal organization and function of HSCs, which declines with age. This approach has the potential to ameliorate aging-associated diseases, improve immune function, and enhance treatment outcomes for blood disorders. The company's therapeutic strategy focuses on attenuating Cdc42 activity to reverse the aging process in HSCs and promote healthier blood cell development.
Target Audience
The primary target audience includes patients with aging-related blood disorders, such as multiple myeloma and myelodysplasia syndromes, as well as individuals experiencing age-related decline in immune function.
Features
- Pharmacological targeting of Cdc42 activity in hematopoietic stem cells
- Rejuvenation of aged HSCs to restore normal function
- Improvement of blood cell production and immune function
- Potential treatment for aging-associated diseases like multiple myeloma and myelodysplasia syndromes
- Novel therapeutic approaches to re-order and rejuvenate HSC function